In the global intention-to-treat population, Pola-R-CHP showed significant progression-free survival benefit over R-CHOP ...

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to UB-VV111 for the treatment of ...

Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

Blood cancers such as leukemia, lymphoma, and myeloma often begin in the bone marrow and disrupt normal blood cell formation.

Naïve B cells exit quiescence and enter a proliferative state upon activation, ultimately differentiating into antibody-secreting or memory B cells. Toll-like receptor (TLR) ligands, such as ...

By examining genomic variation more closely, scientists can now identify new disease connections with greater speed and accuracy. For centuries, scientists have recognized that certain illnesses can ...

Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain ...

As our hair goes gray and our muscles weaken with age, our immune system also changes. In particular, the stem cells that ...

Chinese researchers have developed a novel method to efficiently engineer natural killer (NK) cells for cancer immunotherapy.